Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

INcrease Of VAgal TonE in CHF

Study:

INcrease Of VAgal TonE in CHF (INOVATE-HF) - A Randomized Study to Establish the Safety and Efficacy of CardioFitĀ® for the Treatment of Subjects With Heart Failure and Left Ventricular Dysfunction

Rationale:

n/a

Purpose:

The purpose of the INOVATE-HF study is to demonstrate the long-term safety and efficacy of vagus nerve stimulation with the CardioFitĀ® system for the treatment of subjects with Heart Failure.

Study Status: Recruiting

Recruiting:
n/a

Condition Intervention Phase
Left Ventricular Dysfunction
Heart Failure
Device: CardioFitĀ® System
Other: Standard of Care
Phase 3

Verified by BioControl Medical October, 2013

Sponsored by: BioControl Medical
Information provided by: BioControl Medical
ClinicalTrials.gov identifier: NCT01303718

Study Type: Interventional

Study Design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Cleveland Clinic Florida
Weston, Florida 33331
United States

Cleveland Clinic Foundation
Cleveland, Ohio 44195
United States

Douglas L. Mann, MD., Study Chair
Susan Petersen-Stejskal., Study Director

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site